Detalles de la búsqueda
1.
Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease.
J Rheumatol;
51(5): 529-537, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38428964
2.
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.
Lancet Rheumatol;
6(1): e21-e30, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38258675
3.
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.
Ann Rheum Dis;
83(5): 680-682, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38199795
4.
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study.
Rheumatology (Oxford);
2023 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070152
5.
Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study.
medRxiv;
2023 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37873462
6.
Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review.
Curr Rheumatol Rep;
25(11): 236-245, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37597102
7.
Differences in Primary Care Appointment Availability and Wait Times by Neighborhood Characteristics: a Mystery Shopper Study.
J Gen Intern Med;
33(9): 1441-1443, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29869139
Resultados
1 -
7
de 7
1
Próxima >
>>